Atlas Trials

Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours

Clinical trial NCT03415100 · UNKNOWN

Trial details

NCT number
NCT03415100
Sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumours
Start date
2018-01-02
Primary completion
2019-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.